Maximo II Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Maximo® II CRT-D is a high energy, wireless device with proven shock reduction and features to ensure CRT.
How It Works
Maximo® II CRT-D offers heart failure and diagnostic features to ensure CRT therapy and assess patient status with the Cardiac Compass Report®.
Along with the Attain® Left Heart Leads and Delivery Systems and remote patient care with CareLink® Network, Medtronic offers a comprehensive approach to CRT patients - providing tools to enable implant success, features for CRT assurance, and insight into a patient's clinical status.
Important Safety Information
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features.
Key Features
- Ensure CRT solutions maintain biventricular pacing during atrial fibrillation
- Device diagnostics with comprehensive diagnostic reports to help assess a patient’s clinical status
- Timely, efficient remote follow-up with Medtronic CareLink Network
- Proven shock reduction that can safely eliminate 3 out of 4 shocks1
- Conexus® Wireless Telemetry for secure and convenient patient management
References
- Wathen MS, DeGroot PJ, Sweeney MO, et al, for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. October 26, 2004;110(17):2591-2596.
Specifications
BOS* 7.7 seconds
RRT** 9.3 seconds
Longevity 6.0 years
Size 38 cc
Weight 68 g
* Beginning of Service
**Recommended Replacement Time
Reference
Medtronic Maximo II CRT-D Clinician Manual.